Compounds > safingol

safingol and Leukemia, Myeloid, Acute

safingol has been researched along with Leukemia, Myeloid, Acute in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bucki, R; Chabowska, A; Durnaś, B; Góźdź, S; Marzec, M; Pasiarski, M; Wątek, M; Wolak, P; Wollny, T; Żendzian-Piotrowska, M1
Bunte, RM; Chiu, GN; Chng, WJ; Ling, LU; Tan, KB2
Bell, RM; Hannun, YA; Kinkade, JM; Merrill, AH; Sereni, AM; Stevens, VL1

Other Studies

4 other study(ies) available for safingol and Leukemia, Myeloid, Acute

ArticleYear
Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia.
    Lipids in health and disease, 2017, Dec-08, Volume: 16, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Case-Control Studies; Ceramides; Female; Gelsolin; Humans; Leukemia, Myeloid, Acute; Lysophospholipids; Male; Middle Aged; Sphingosine

2017
Liposomal codelivery of a synergistic combination of bioactive lipids in the treatment of acute myeloid leukemia.
    Nanomedicine (London, England), 2014, Volume: 9, Issue:11

    Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Ceramides; Cholesterol; Chromatography, Liquid; Drug Delivery Systems; Female; Humans; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Lipids; Liposomes; Mice; Mice, Inbred BALB C; Mice, SCID; Phosphatidylcholines; Sphingosine; Tandem Mass Spectrometry; U937 Cells; Xenograft Model Antitumor Assays

2014
In vivo efficacy of a novel liposomal formulation of safingol in the treatment of acute myeloid leukemia.
    Journal of controlled release : official journal of the Controlled Release Society, 2012, Jun-10, Volume: 160, Issue:2

    Topics: Animals; Antineoplastic Agents; Cell Culture Techniques; Cell Survival; Drug Compounding; Female; Hemolysis; Humans; Leukemia, Experimental; Leukemia, Myeloid, Acute; Mice; Mice, Inbred BALB C; Mice, SCID; Solubility; Sphingosine; Survival Analysis; U937 Cells; Xenograft Model Antitumor Assays

2012
Inhibition of phorbol ester-dependent differentiation of human promyelocytic leukemic (HL-60) cells by sphinganine and other long-chain bases.
    The Journal of biological chemistry, 1986, Sep-25, Volume: 261, Issue:27

    Topics: Acid Phosphatase; Binding, Competitive; Cell Adhesion; Cell Differentiation; Cell Line; Humans; Kinetics; Leukemia, Myeloid, Acute; Phorbol 12,13-Dibutyrate; Phorbol Esters; Protein Kinase C; Sphingosine; Structure-Activity Relationship; Tetradecanoylphorbol Acetate

1986